Back to Archived Journals » Core Evidence » Volume 6

Core Evidence ceased publishing in November 2022. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Core Evidence


      

Archive: Volume 6, 2011

Review

Lixisenatide: evidence for its potential use in the treatment of type 2 diabetes

Barnett AH

Core Evidence 2011, 6:67-79

Published Date: 8 September 2011

Review

Aztreonam (for inhalation solution) for the treatment of chronic lung infections in patients with cystic fibrosis: an evidence-based review

Kirkby S, Novak K, McCoy K

Core Evidence 2011, 6:59-66

Published Date: 11 August 2011

Review

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Jain S, Diefenbach C, Zain J, O'Connor OA

Core Evidence 2011, 6:43-57

Published Date: 4 April 2011

Review

Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes

Bernardo Lombo, José G Díez

Core Evidence 2011, 6:31-42

Published Date: 17 March 2011

Review

Plerixafor for autologous CD34+ cell mobilization

Huda Salman, Hillard M Lazarus

Core Evidence 2011, 6:23-29

Published Date: 8 February 2011

Review

Evidence-based assessment of potential use of fingolimod in treatment of relapsing multiple sclerosis

Emilio Portaccio

Core Evidence 2011, 6:13-21

Published Date: 6 January 2011

Review

Romidepsin: evidence for its potential use to manage previously treated cutaneous T cell lymphoma

Brian Poligone, Janet Lin, Catherine Chung

Core Evidence 2011, 6:1-12

Published Date: 22 December 2010